Evidence map›Paper›PMID 34609597›Full record

ArticleRheumatology international2021

Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017.

Ivet Morales-Etchegaray, Mario Garcia-Carrasco, Pamela Munguía-Realpozo, Claudia Mendoza-Pinto, Socorro Méndez-Martínez, Olivia Navarro-Milán, Sandra Karina Velez-Pelcastre, Carlos Javier Pineda-Villaseñor

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ivet Morales-EtchegarayDepartment of Rheumatology, Medicine School, Meritorious Autonomous University of Puebla, Puebla, México.ORCID http://orcid.org/0000-0002-5857-4299
Mario Garcia-CarrascoDepartment of Rheumatology, Medicine School, Meritorious Autonomous University of Puebla, Puebla, México.ORCID http://orcid.org/0000-0003-1696-9871
Pamela Munguía-RealpozoDepartment of Rheumatology, Medicine School, Meritorious Autonomous University of Puebla, Puebla, México.ORCID http://orcid.org/0000-0002-6967-7939
Claudia Mendoza-PintoDepartment of Rheumatology, Medicine School, Meritorious Autonomous University of Puebla, Puebla, México. cmp_26@yahoo.com.mx.ORCID http://orcid.org/0000-0002-5101-7705
Socorro Méndez-MartínezResearch in Health Coordination, Mexican Social Security Institute, Puebla, México.ORCID http://orcid.org/0000-0001-7463-0580
Olivia Navarro-MilánDepartment of Rheumatology, Medicine School, Meritorious Autonomous University of Puebla, Puebla, México.ORCID http://orcid.org/0000-0003-2845-2642
Sandra Karina Velez-PelcastreDepartment of Rheumatology, Medicine School, Meritorious Autonomous University of Puebla, Puebla, México.ORCID http://orcid.org/0000-0003-1563-3989
Carlos Javier Pineda-VillaseñorDivision of Musculoskeletal and Rheumatic Disorders, National Rehabilitation Institute Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-0544-7461

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim was to analyze the distribution and trends of deaths reported for rheumatoid arthritis (RA) in Mexico in 1998-2017. We carried out a cross-sectional study. Data were obtained from Dynamic Cubes, General Direction of Health Information, on deaths related to RA in Mexico. Seropositive RA was diagnosed using the International Classification of Diseases version 10. Variables were categorized by diagnosis, age, and gender. Time trends of age-standardized mortality rates (ASMRs) were analyzed for RA, and the annual percent change (APC) was estimated using Joinpoint trend analysis. We found 714 deaths mentioned as RA and 9,749,956 non-RA deaths between 1998 and 2017. Overall RA mortality decreased from 0.14 in 2004 to 0.04 per 100 000 in 2017 (APC: - 10.3%; 95% CI - 16.5%, - 3.3%), while the non-RA ASMR remained stable. In females, there was an initial increase of 27.3% per year through 1998-2004 and a reduction of - 11.7% per year subsequently, while in males, the APC remained stable between 1998 and 2017. The trend for RA mortality resulted in a cumulative change in the ratio of RA ASMR to non-RA ASMR of - 20.6% in females and + 3.2% in males. Although mortality attributable to RA increased from 1998 to 2004 in Mexico, it began to improve after 2004, particularly in females. Prospective, population-based data could help to identify risk factors that could be altered to improve outcomes.

Indexed as

Arthritis, RheumatoidCross-Sectional StudiesFemaleHumansMaleMexicoSex DistributionMortality trendsPopulation-based studyRheumatoid arthritis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.